Literature DB >> 29380902

Probing the striatal dopamine system for a putative neuroprotective effect of deep brain stimulation in Parkinson's disease.

Gian Pal1, Bichun Ouyang1, Leo Verhagen1, Geidy Serrano2, Holly A Shill2, Charles H Adler2,3, Thomas G Beach2,3, Jeffrey H Kordower1,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29380902      PMCID： PMC5988253          DOI： 10.1002/mds.27280

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  10 in total

1.  Disease duration and the integrity of the nigrostriatal system in Parkinson's disease.

Authors:  Jeffrey H Kordower; C Warren Olanow; Hemraj B Dodiya; Yaping Chu; Thomas G Beach; Charles H Adler; Glenda M Halliday; Raymond T Bartus
Journal:  Brain       Date:  2013-08       Impact factor: 13.501

Review 2.  Is deep brain stimulation neuroprotective if applied early in the course of PD?

Authors:  P David Charles; Chandler E Gill; Thomas L Davis; Peter E Konrad; Alim-Louis Benabid
Journal:  Nat Clin Pract Neurol       Date:  2008-07-01

3.  Protection of nigral cell death by bilateral subthalamic nucleus stimulation.

Authors:  Yasin Temel; Veerle Visser-Vandewalle; Süleyman Kaplan; Ramazan Kozan; Marc A R C Daemen; Arjan Blokland; Christoph Schmitz; Harry W M Steinbusch
Journal:  Brain Res       Date:  2006-09-26       Impact factor: 3.252

4.  Subthalamic beta oscillations are attenuated after withdrawal of chronic high frequency neurostimulation in Parkinson's disease.

Authors:  Megan H Trager; Mandy Miller Koop; Anca Velisar; Zack Blumenfeld; Judy Syrkin Nikolau; Emma J Quinn; Talora Martin; Helen Bronte-Stewart
Journal:  Neurobiol Dis       Date:  2016-08-21       Impact factor: 5.996

5.  Dopaminergic cells in the periaqueductal grey matter of MPTP-treated monkeys and mice; patterns of survival and effect of deep brain stimulation and lesion of the subthalamic nucleus.

Authors:  Victoria E Shaw; Kevin A Keay; Keyoumars Ashkan; Alim-Louis Benabid; John Mitrofanis
Journal:  Parkinsonism Relat Disord       Date:  2010-03-12       Impact factor: 4.891

6.  Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.

Authors:  Gian D Pal; Bichun Ouyang; Geidy Serrano; Holly A Shill; Christopher Goetz; Glenn Stebbins; Leo Verhagen Metman; Erika Driver-Dunckley; Shyamal H Mehta; John N Caviness; Marwan N Sabbagh; Charles H Adler; Thomas G Beach
Journal:  Mov Disord       Date:  2016-12-02       Impact factor: 10.338

7.  Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Geidy Serrano; Holly A Shill; Douglas G Walker; LihFen Lue; Alex E Roher; Brittany N Dugger; Chera Maarouf; Alex C Birdsill; Anthony Intorcia; Megan Saxon-Labelle; Joel Pullen; Alexander Scroggins; Jessica Filon; Sarah Scott; Brittany Hoffman; Angelica Garcia; John N Caviness; Joseph G Hentz; Erika Driver-Dunckley; Sandra A Jacobson; Kathryn J Davis; Christine M Belden; Kathy E Long; Michael Malek-Ahmadi; Jessica J Powell; Lisa D Gale; Lisa R Nicholson; Richard J Caselli; Bryan K Woodruff; Steven Z Rapscak; Geoffrey L Ahern; Jiong Shi; Anna D Burke; Eric M Reiman; Marwan N Sabbagh
Journal:  Neuropathology       Date:  2015-01-26       Impact factor: 1.906

8.  Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation.

Authors:  R Hilker; A T Portman; J Voges; M J Staal; L Burghaus; T van Laar; A Koulousakis; R P Maguire; J Pruim; B M de Jong; K Herholz; V Sturm; W-D Heiss; K L Leenders
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

9.  Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease.

Authors:  Gianluigi Lunardi; Salvatore Galati; Domenicantonio Tropepi; Vincenzo Moschella; Livia Brusa; Mariangela Pierantozzi; Alessandro Stefani; Silvia Rossi; Francesco Fornai; Ernesto Fedele; Paolo Stanzione; Atticus H Hainsworth; Antonio Pisani
Journal:  Parkinsonism Relat Disord       Date:  2008-11-17       Impact factor: 4.891

10.  Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys.

Authors:  Bradley A Wallace; Keyoumars Ashkan; Claire E Heise; Kelly D Foote; Napoleon Torres; John Mitrofanis; Alim-Louis Benabid
Journal:  Brain       Date:  2007-06-20       Impact factor: 13.501
  10 in total
  2 in total

1.  BDNF provides many routes toward STN DBS-mediated disease modification.

Authors:  D Luke Fischer; Caryl E Sortwell
Journal:  Mov Disord       Date:  2018-11-15       Impact factor: 10.338

Review 2.  How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?

Authors:  Philipp Mahlknecht; Thomas Foltynie; Patricia Limousin; Werner Poewe
Journal:  Mov Disord       Date:  2022-05-12       Impact factor: 9.698
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.